Clinical trials: Functional Dyspepsia
Functional Dyspepsia
To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia
- Trial name
- NCT00323817
- Testing
- Z-338
- Where
- Belgium
- Volunteers
- 282 people
- Sponsor
- Zeria Pharmaceutical
Irritable Bowel Syndrome, Crohn Disease
Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis
The SIMBA Capsule is a small, single-use, ingestible capsule that allows for the non-invasive sampling of small bowel contents using purely mechanical means.
- Conditions
- Irritable Bowel Syndrome, Crohn Disease, Celiac Disease, Ulcerative Colitis
- Trial name
- NCT05633706
- Testing
- fluid biopsy capsule
- Where
- Canada
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- Nimble Science Ltd.
Helicobacter Pylori Infection
Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia
Treatment for H. pylori eradication includes antibiotics. The treatment has decreased its efficiency (lower capability to eradicate the infection) due to increasing antibiotic resistance in the population.
- Trial name
- NCT04473079
- Testing
- Lacidofil
- Where
- Thailand
- Volunteers
- 90 people
- Sponsor
- Lallemand Health Solutions
Dyspepsia
Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia
Multi-center, randomized, superiority, double blind clinical trial to asses the efficacy of fixed-dose combination of bromopride and simethicone versus isolated bromopride on research participants diagnosed with functional…
- Trial name
- NCT02604576
- Testing
- FDC Bromopride 10 mg and Simethicone 80 mg, Bromopride 10 mg
- Where
- 10 sites in Brazil
- Volunteers
- 339 people
- Sponsor
- EMS
Functioanl Dyspepsia
The Effect of Z-338 in Subjects With Functional Dyspepsia
Z-338; PhaseIIb, Single-centre, Randomized, Double-blind, Placebo-controlled, Parallel group study in Subjects with Functional Dyspepsia, evaluate the motility of gastro-duodenum by ultrasound
- Trial name
- NCT00458328
- Testing
- Z-338
- Where
- Japan
- Volunteers
- 40 people
- Sponsor
- Zeria Pharmaceutical
Functional Dyspepsia
Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients
The purpose of this study is to evaluate the safety and validity of Aolanti Weipang Tablets in Patients with Postprandial Discomfort Syndrome of Functional Dyspepsia
- Trial name
- NCT03971383
- Testing
- Aolanti Weipang Tablets
- Where
- China
- Volunteers
- 236 people
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Functional Gastrointestinal Disorders
Study in Patients Suffering From Heartburn and Backward Flow of Stomach Liquid Into the Esophagus
In this study researchers want to learn more about the effectiveness of Iberogast® in patients with irritable stomach and concomitant chronic or recurrent heartburn and backward flow of stomach liquid into the esophagus.
- Trial name
- NCT04059900
- Testing
- STW5 (Iberogast®, BAY98-7411)
- Where
- Germany
- Volunteers
- 64 people
- Sponsor
- Bayer
Postprandial Distress Syndrome
Acotiamide vs Itopride in Postprandial Distress Syndrome
The goal of this study is to "To compare the efficacy and safety of Acotiamide versus Itopride in patient with post prandial distress syndrome type of functional dyspepsia"
- Trial name
- NCT07174297
- Testing
- Acotiamide
- Volunteers
- 152 people
- Sponsor
- Getz Pharma
Functional Dyspepsia
Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia
The aim of this study is to show non-inferiority of two brands of simeticone in adult patients suffering from functional dyspepsia.
- Trial name
- NCT02660372
- Testing
- Imonogas, Espumisan
- Where
- Russia
- Volunteers
- 210 people
- Sponsor
- Johnson & Johnson Consumer and Personal Products Worldwide
Functional Dyspepsia
Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
The study is conducted in patients with functional dyspepsia or chronic gastritis. The purpose of this study is to: assess whether the dose of Itopride Hydrochloride 150 mg extended release tablets, taken once daily has a similar…
- Trial name
- NCT06217393
- Testing
- Itopride Hydrochloride 150 mg extended release tablets, Itopride Hydrochloride 50 mg film coated tablets
- Where
- 19 sites in Armenia, Malaysia and 3 more
- Volunteers
- 564 people
- Sponsor
- Abbott
Stress, Dyspepsia
Clinical Study of De-Stress & Happy Gut Powder for Stress and Indigestion in Adults.
The current study focuses on clinical validation of efficacy of nutraceutical product in relieving stress and functional dyspepsia symptoms in adults for gut health.
- Conditions
- Stress, Dyspepsia, Indigestion
- Trial name
- NCT06568965
- Testing
- De-stress & happy gut powder-U001, De-Stress & Happy Gut powder-I001
- Volunteers
- 81 people, healthy volunteers welcome
- Sponsor
- Herbolab India Pvt. Ltd.
Functional Dyspepsia
A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults
This study evaluates whether YM443 causes any changes in the electrocardiogram of healthy adults.
- Trial name
- NCT00850746
- Testing
- YM443, Moxifloxacin
- Where
- United States
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Astellas Pharma Inc
Dyspepsia
EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolia Raddi) COMPARED TO OMEPRAZOLE IN DYSPEPPSIA
This is a prospective, randomized, double - blind study of 474 male and female volunteers with dyspeppsia diagnosed at the Oswaldo Cruz University Hospital Gastroenterology Outpatient Clinic from March 2025 to March 2027.
- Trial name
- NCT04069286
- Testing
- Oral Aroeira, Omeprazole 20Mg Capsule
- Volunteers
- 474 people
- Sponsor
- Infan Industria Quimica Farmaceutica Nacional
Dyspepsia, Functional Gastrointestinal Disorders
Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
The objectives of this study are to determine the safety and efficacy of IW-9179 administered to patients with functional dyspepsia (FD).
- Trial name
- NCT01712412
- Testing
- IW-9179
- Where
- 15 sites in Belgium, Netherlands
- Volunteers
- 10 people
- Sponsor
- Ironwood Pharmaceuticals, Inc.
Functional Dyspepsia
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia
The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.
- Trial name
- NCT03024086
- Testing
- DWJ1252, Gasmotin
- Where
- South Korea
- Volunteers
- 124 people
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
Dyspepsia, Functional Dyspepsia
A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia
To examine the safety and efficacy of Z-338 (YM443) after long-term administration in patients with functional dyspepsia, and also to examine the pattern of long-term administration.
- Trial name
- NCT00764374
- Testing
- YM443
- Where
- 4 sites in Japan
- Volunteers
- 412 people
- Sponsor
- Astellas Pharma Inc
Functional Dyspepsia
A Study to Demonstrate the Efficacy and Safety of Motilitone®
This is a phase IV , comparative study to evaluate the efficacy and safety of Motiltone® in treatment of the patients with functional dyspepsia.
- Trial name
- NCT01817465
- Testing
- Motilitone ®, Pantoline®, Motilitone® and Pantoline®
- Where
- South Korea
- Volunteers
- 389 people
- Sponsor
- Dong-A ST Co., Ltd.
Functional Gastrointestinal Disorders, Abdominal Pain
Pepsin in Patients With Functional Dyspepsia
This non-interventional, observational study investigates the course of symptoms in patients with functional dyspepsia under treatment with a fixed combination of pepsin and amino acid hydrochloride over a period of approximately…
- Conditions
- Functional Gastrointestinal Disorders, Abdominal Pain, Dyspepsia, Nausea
- Trial name
- NCT03076411
- Testing
- Pepsin
- Where
- Germany
- Volunteers
- 97 people
- Sponsor
- Nordmark Arzneimittel GmbH & Co. KG
Functional Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia, Irritable Bowel Syndrome
A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting
This is an observational study in which data from people with functional gastrointestinal disorders who decide on their own or by recommendation of their doctors or pharmacists to take Iberogast Advance are collected and studied.
- Conditions
- Functional Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia, Irritable Bowel Syndrome, Functional Dyspepsia
- Trial name
- NCT05389709
- Testing
- Iberogast (STW5-II, BAY98-7410)
- Where
- Germany
- Volunteers
- 184 people
- Sponsor
- Bayer
Functional Dyspepsia
Clinical Trial of DA-5212 in Patients with Functional Dyspepsia
This study is to evaluate efficacy and safety of DA-5212 in patients with functional dyspepsia
- Trial name
- NCT05842408
- Testing
- DA-5212, DA-5212-R
- Where
- South Korea
- Volunteers
- 384 people
- Sponsor
- Dong-A ST Co., Ltd.